Ridgeback Biotherapeutics LP

Miami, FL Ridgeback Biotherapeutics L.P.

UEI
J486UJLMAKB5
CAGE
8B1C9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Business
Entity structure
Partnership or Limited Liability Partnership
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
3480 Main Hwy #402, Miami, FL 33133, USA
Website
ridgebackbio.com
Founded
2016
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Ridgeback Biotherapeutics LP's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
CMC efforts for MAB114 for the development and treatment of ebola. Contract · 75A50120C00009 Office of the Assistant Secretary for Preparedness and Response $19,311,430
CMC efforts for MAB114 development for the treatment of ebola. Contract · 75A50119C00059 Office of the Assistant Secretary for Preparedness and Response $13,988,547

Quick answers

What is Ridgeback Biotherapeutics LP's UEI?

Ridgeback Biotherapeutics LP's Unique Entity ID (UEI) in SAM.gov is J486UJLMAKB5.

What is Ridgeback Biotherapeutics LP's CAGE code?

Ridgeback Biotherapeutics LP's CAGE code is 8B1C9.

What is Ridgeback Biotherapeutics LP's primary NAICS code?

Ridgeback Biotherapeutics LP's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Ridgeback Biotherapeutics LP located?

Ridgeback Biotherapeutics LP's physical address in SAM.gov is 3480 Main Hwy #402, Miami, FL 33133, USA.

Is Ridgeback Biotherapeutics LP registered in SAM.gov?

Yes. Ridgeback Biotherapeutics LP's SAM.gov registration is active through March 2, 2027.

What is Ridgeback Biotherapeutics LP's most recent federal award?

Ridgeback Biotherapeutics LP's most recent federal contract award is CMC efforts for MAB114 for the development and treatment of ebola (75A50120C00009), from Office of the Assistant Secretary for Preparedness and Response, on March 19, 2020.

On GovTribe

See Ridgeback Biotherapeutics LP's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login